Vance B. Matthews - Concepedia

Author

Vance B. Matthews

The University of Western Australia ORCID

Also Known As

V. B. Matthews, V. Matthews, VANCE MATTHEWS, Vance B Matthews, Vance B. Matthews, Vance Matthews

Publications

593

Citations

H-Index

Concepts

All Affiliations

The University of Western Australia Royal Perth Hospital Baker Heart and Diabetes Institute Harry Perkins Institute of Medical Research Curtin University

About

Vance B. Matthews is an author at The University of Western Australia specializing in medicine, physiology, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	154
2	Health Sciences	2	2	136
3	Metabolism	2	2	136
4	Biochemistry	1	1	93
5	Diabetes	1	1	93

Vance B. Matthews

Publications

472

Citations

H-Index

Page 1

	Year	Citations
BDNF, Metabolic Risk Factors, and Resistance Training in Middle-Aged Individuals Itamar Levinger, Craig A. Goodman, Vance B. Matthews, Medicine & Science in Sports & Exercise	2008	111
Supplementation of a High-Fat Diet with Chlorogenic Acid Is Associated with Insulin Resistance and Hepatic Lipid Accumulation in Mice Aidilla Mubarak, Jonathan M. Hodgson, Michael Considine, Journal of Agricultural and Food Chemistry ObesityMetabolic SyndromeInsulin ResistanceNutritionMetabolic Disorder	2013	93
Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet Si Tan, José A. Caparrós‐Martín, Vance B. Matthews, Scientific Reports	2018	58
Green coffee polyphenols do not attenuate features of the metabolic syndrome and improve endothelial function in mice fed a high fat diet J.D. Li Kwok Cheong, Kevin D. Croft, Peter J. Henry, Archives of Biochemistry and Biophysics ObesityMetabolic SyndromeLipid NutritionPhysiologyEndothelial Function	2014	43
Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension Shaun Frost, Janis M. Nolde, Justine Chan, Scientific Reports	2021	33
ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor‐α Jeremy B. M. Jowett, Yasunori Okada, Peter J. Leedman, Immunology and Cell Biology	2012	23
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy Lakshini Y. Herat, Jennifer R. Matthews, Wei E. Ong, Frontiers in Bioscience-Landmark	2022	19
SGLT-2 inhibitor induced sympathoinhibition: a novel mechanism for cardiorenal protection Vance B. Matthews, R. Elliot, Caroline Rudnicka, Obesity Research & Clinical Practice Cardiorenal SyndromesCardiovascular DiseaseMedicinePhysiologyCardiovascular Pharmacology	2019	18
ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice Lakshini Y. Weerasekera, Caroline Rudnicka, Qing-Xiang Sang, Mediators of Inflammation	2017	14
Microglia are both a source and target of extracellular cyclophilin A Gurkiran Kaur Flora, Ryan S. Anderton, Bruno P. Meloni, Heliyon	2019	13

Page 1